Watchlist Wire

A drug company posted results on an experimental cancer treatment and gained 177% in a single session. The next day it handed back a quarter of that. No new information in between. Atlas and Michael use that pattern to...

Two weeks ago the market was pricing a rate cut. That is over. The 30-year Treasury yield hit its highest level in nearly two decades, oil rose about 5% after a US-Iran diplomatic understanding expired, and the Fed...

Inflation cooled, small caps hit records three times, and consumer spending fell off a cliff. All in the same five days.

A company raises $12 million. The headline says the offering closed, and then coverage stops. Almost nobody asks the obvious question: to do what? There is one paragraph in every offering document that answers it, and...

The economy shed 23,000 jobs in July when forecasters expected a gain of nearly 90,000, and May and June were revised down by another 103,000 combined. The market rallied anyway. The Nasdaq gained close to 5% on the...

An index that rose while most of its members fell, one company delivering nearly the entire gain, and a central bank splitting in public for the first time in a decade.

A company trades at four dollars all day. At five past four, after the bell, it agrees to sell twelve million dollars of stock at three dollars and twenty cents, with a warrant attached to every share. By morning the...

A company trades at four dollars all day. At five past four, after the bell, it agrees to sell twelve million dollars of stock at three dollars and twenty cents, with a warrant attached to every share. By morning the...

This is a short one, and a different one. No filing walkthrough this week. Atlas and Michael lay out where the show is heading. Starting now, Watchlist Wire runs two episodes a week instead of one. One stays the...

Shares outstanding is one number. The float, the shares actually free to trade, is another, and in micro-caps the gap between them decides how a stock moves. In this episode, Atlas and Michael close the share-count arc...

Shares are not the only thing a micro-cap hands out when it raises. Attached to many of those deals are warrants: the right to buy new stock from the company later, at a fixed price. They sit quietly in the filings...

An S-3 shelf registration is a loaded weapon. An at-the-market facility is the trigger. Together they let a company sell new shares into the open market quietly, sometimes daily, and most holders never notice until the...

Buried in the footnotes of some annual reports is a single sentence that changes everything: substantial doubt about the ability to continue as a going concern. It’s quiet. No bold type, no press release. And it’s one...

Every time a corporate insider buys or sells their own company's stock, a public document gets filed within two business days. It's free. It's on the SEC website. And almost no retail investor reads it. It's called a...

<p>Your hundred shares become ten. The price multiplies by ten. The math comes out flat. So why do experienced micro-cap investors treat a reverse split as a red flag?</p><p><br></p><p>Because in this market, the math...